- Identify ideal patients for anti-IC-23 therapy
- Understand the mechanism of action of anti-IC-23 drugs
- Recognize the risks and benefits of anti-IL-23 therapy
Presented by: Mark Lebwohl, MD
Valid for credit through: 12/31/2025
Lecture objectives:
- Identify ideal patients for anti-IC-23 therapy
- Understand the mechanism of action of anti-IC-23 drugs
- Recognize the risks and benefits of anti-IL-23 therapy
The American Osteopathic College of Dermatology (AOCD) is accredited by the American Osteopathic Association (AOA) to provide Category 1A continuing medical education for physicians.
The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
The American Osteopathic College of Dermatology (AOCD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide AMA PRA Category 1 Credits™ continuing medical education for physicians.
The American Osteopathic College of Dermatology (AOCD) designates this program for a maximum of 1 AMA PRA Category 1 Credit™, and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
Participants may ask questions of a content expert. A response will be given within 7 business days. Please direct questions to: swood@aocd.org.
The lectures made available online by the American Osteopathic College of Dermatology (AOCD) are the intellectual property of the presenter and the AOCD for the purposes of educating the medical community. Any duplication or retransmission of this content without the express written consent of the AOCD is strictly prohibited.
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 |